





The latest eyelash-enhancing drug from Allergan is now FDA approved and available for consumer use.
Last month, the FDA gave Botox/Juvederm manufacturer Allergan its stamp of approval for Latisse. Now, the hot new drug is becoming available through certain providers.
What is Latisse? If you haven’t heard yet, it is a special eyelash enhancer that gets applied to the base of the lashes. Latisse keeps hairs in their growth phase, producing darker, thicker and longer eyelashes. The effects of Latisse are highly desirable, but not permanent. You have to keep using it or your eyelashes will return to their original state.
During clinical trials for a glaucoma eye drop called Lumigan, researchers noticed an unintended side effect; patients exhibited longer, fuller lashes. Further research was conducted, the active ingredient (bimatoprost) was reduced, and now many patients can have the long, desirable eyelashes they’ve always wanted.
Call us at Cosmetic Surgery of Las Vegas for further details!
Leave a comment